Log In
Print
BCIQ
Print
Print this Print this
 

SER-109

  Manage Alerts
Collapse Summary General Information
Company Seres Health Inc.
DescriptionOral mixture of microbiome organisms
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic
Latest Stage of DevelopmentPhase I/II
Standard IndicationClostridium
Indication DetailsTreat recurrent Clostridium difficile infection (CDI)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today